Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin D3 binding activity during leukemic cell differentiation

J Feldman1, M H Federico, S Sonohara

  • 1Departamento de Clínica Médica, Faculdade de Medicina, Universidade de São Paulo, Brasil.

Leukemia Research
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combining structural modeling and deep learning to calculate the E. coli protein interactome and functional networks.

Nature communications·2026
Same author

Combining structural modeling and deep learning to calculate the <i>E. coli</i> protein interactome and functional networks.

bioRxiv : the preprint server for biology·2025
Same author

Study of upright patient positioning reproducibility in image-guided proton therapy for head and neck cancers.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2024
Same author

Impact of an automated report comparison tool on trainee report modification rate at a tertiary hospital.

Clinical radiology·2024
Same author

Searching for clinical trials in oncology: finding a path through the maze.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Differentiation of leukemia cells reduces 1,25-dihydroxycholecalciferol (1,25(OH)2D3) binding. Immature leukemia cells show higher 1,25(OH)2D3 receptor levels than mature cells, suggesting it may indicate functional immaturity.

Area of Science:

  • Cell biology
  • Endocrinology
  • Hematology

Background:

  • The human promyelocytic leukemia cell line HL60 can differentiate along myelocytic or monocytic pathways.
  • 1,25-dihydroxycholecalciferol (1,25(OH)2D3) is a biologically active form of Vitamin D.
  • Vitamin D receptors are involved in cell differentiation and proliferation.

Purpose of the Study:

  • To investigate the relationship between 1,25(OH)2D3 binding and cell differentiation in HL60 cells.
  • To compare 1,25(OH)2D3 binding levels in leukemia blasts and normal lymphocytes.
  • To determine if 1,25(OH)2D3 receptor levels can serve as a marker of cellular immaturity.

Main Methods:

  • Inducing differentiation of HL60 cells using retinoic acid (RA), phorbol-myristate acetate (PMA), and gamma interferon (IFN).

Related Experiment Videos

  • Measuring 1,25(OH)2D3 binding in HL60 cells before and after differentiation.
  • Uncoupling differentiation and proliferation using IFN or cell density saturation.
  • Comparing 1,25(OH)2D3 binding in acute lymphocytic leukemia (ALL) blasts and normal mature lymphocytes.

    • Main Results:

    • Differentiation of HL60 cells led to a significant decline in 1,25(OH)2D3 binding.
    • 1,25(OH)2D3 binding correlated better with differentiation than proliferation when these processes were uncoupled.
    • Immature ALL blasts exhibited significantly higher 1,25(OH)2D3 receptor binding compared to normal mature lymphocytes.

    Conclusions:

    • 1,25(OH)2D3 receptor levels decrease during HL60 cell differentiation.
    • 1,25(OH)2D3 receptor expression is associated with the differentiation state of leukemia cells.
    • Elevated 1,25(OH)2D3 receptor levels in leukemia blasts may indicate functional immaturity.